GB201113757D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB201113757D0
GB201113757D0 GBGB1113757.7A GB201113757A GB201113757D0 GB 201113757 D0 GB201113757 D0 GB 201113757D0 GB 201113757 A GB201113757 A GB 201113757A GB 201113757 D0 GB201113757 D0 GB 201113757D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1113757.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Autifony Therapeutics Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB1113757.7A priority Critical patent/GB201113757D0/en
Publication of GB201113757D0 publication Critical patent/GB201113757D0/en
Priority to MX2013006343A priority patent/MX338489B/en
Priority to SG2013035357A priority patent/SG190203A1/en
Priority to US13/991,486 priority patent/US9346790B2/en
Priority to KR1020137017537A priority patent/KR101862375B1/en
Priority to CN201180058712.3A priority patent/CN103328467B/en
Priority to EP11805571.4A priority patent/EP2649066B1/en
Priority to ES11805571.4T priority patent/ES2560304T3/en
Priority to BR112013013914-5A priority patent/BR112013013914B1/en
Priority to PCT/GB2011/052414 priority patent/WO2012076877A1/en
Priority to DK11805571.4T priority patent/DK2649066T3/en
Priority to PL11805571T priority patent/PL2649066T3/en
Priority to AU2011340258A priority patent/AU2011340258C1/en
Priority to JP2013542606A priority patent/JP5913357B2/en
Priority to CA2817205A priority patent/CA2817205C/en
Priority to EA201390609A priority patent/EA023768B1/en
Priority to EA201490922A priority patent/EA027532B1/en
Priority to SG11201402529RA priority patent/SG11201402529RA/en
Priority to US14/361,510 priority patent/US9133175B2/en
Priority to IL226256A priority patent/IL226256A0/en
Priority to HK14103468.1A priority patent/HK1190395A1/en
Priority to ZA2014/03529A priority patent/ZA201403529B/en
Priority to US14/816,476 priority patent/US9422272B2/en
Priority to JP2016023519A priority patent/JP6118927B2/en
Priority to US15/093,004 priority patent/US20160251340A1/en
Priority to US15/206,465 priority patent/US9833452B2/en
Priority to US15/621,400 priority patent/US10265316B2/en
Priority to IL253102A priority patent/IL253102B/en
Priority to IL253104A priority patent/IL253104A0/en
Priority to US15/730,559 priority patent/US10098881B2/en
Priority to US16/125,148 priority patent/US10555945B2/en
Priority to US16/285,996 priority patent/US20190192516A1/en
Priority to US16/725,709 priority patent/US10835534B2/en
Priority to US16/985,160 priority patent/US11197859B2/en
Priority to US17/030,268 priority patent/US11541052B2/en
Priority to US17/517,620 priority patent/US11583527B2/en
Ceased legal-status Critical Current

Links

GBGB1113757.7A 2010-12-06 2011-08-10 Novel compounds Ceased GB201113757D0 (en)

Priority Applications (36)

Application Number Priority Date Filing Date Title
GBGB1113757.7A GB201113757D0 (en) 2011-08-10 2011-08-10 Novel compounds
EA201390609A EA023768B1 (en) 2010-12-06 2011-12-06 HYDANTOIN DERIVATIVES USEFUL AS INHIBITORS OF Kv3 CHANNELS
EP11805571.4A EP2649066B1 (en) 2010-12-06 2011-12-06 Hydantoin derivatives useful as kv3 inhibitors
BR112013013914-5A BR112013013914B1 (en) 2010-12-06 2011-12-06 HIDANTOIN DERIVED COMPOUNDS USEFUL AS KV3 INHIBITORS, USES OF SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITION INCLUDING THEM
US13/991,486 US9346790B2 (en) 2010-12-06 2011-12-06 Hydantoin derivatives useful as Kv3 inhibitors
KR1020137017537A KR101862375B1 (en) 2010-12-06 2011-12-06 Hydantoin derivatives useful as kv3 inhibitors
CN201180058712.3A CN103328467B (en) 2010-12-06 2011-12-06 Hydantoin derivatives as KV3 inhibitor
MX2013006343A MX338489B (en) 2010-12-06 2011-12-06 Hydantoin derivatives useful as kv3 inhibitors.
ES11805571.4T ES2560304T3 (en) 2010-12-06 2011-12-06 Hydantoin derivatives useful as Kv3 inhibitors
SG2013035357A SG190203A1 (en) 2010-12-06 2011-12-06 Hydantoin derivatives useful as kv3 inhibitors
PCT/GB2011/052414 WO2012076877A1 (en) 2010-12-06 2011-12-06 Hydantoin derivatives useful as kv3 inhibitors
DK11805571.4T DK2649066T3 (en) 2010-12-06 2011-12-06 Hydantoin derivatives using as KV3 inhibitors.
PL11805571T PL2649066T3 (en) 2010-12-06 2011-12-06 Hydantoin derivatives useful as kv3 inhibitors
AU2011340258A AU2011340258C1 (en) 2010-12-06 2011-12-06 Hydantoin derivatives useful as Kv3 inhibitors
JP2013542606A JP5913357B2 (en) 2010-12-06 2011-12-06 Hydantoin derivatives useful as KV3 inhibitors
CA2817205A CA2817205C (en) 2010-12-06 2011-12-06 Hydantoin derivatives useful as kv3 inhibitors
US14/361,510 US9133175B2 (en) 2010-12-06 2012-12-06 Compounds
EA201490922A EA027532B1 (en) 2010-12-06 2012-12-06 HYDANTOIN DERIVATIVES USEFUL AS INHIBITORS OF Kv3 CHANNELS
SG11201402529RA SG11201402529RA (en) 2010-12-06 2012-12-06 Hydantoin derivatives useful as kv3 inhibitors
IL226256A IL226256A0 (en) 2010-12-06 2013-05-09 Hydantoin derivatives useful as kv3 inhibitors
HK14103468.1A HK1190395A1 (en) 2010-12-06 2014-04-10 Hydantoin derivatives useful as kv3 inhibitors kv3
ZA2014/03529A ZA201403529B (en) 2010-12-06 2014-05-15 Hydantoin derivatives useful as kv3 inhibitors
US14/816,476 US9422272B2 (en) 2010-12-06 2015-08-03 Compounds
JP2016023519A JP6118927B2 (en) 2010-12-06 2016-02-10 Hydantoin derivatives useful as KV3 inhibitors
US15/093,004 US20160251340A1 (en) 2010-12-06 2016-04-07 Hydantoin derivatives useful as kv3 inhibitors
US15/206,465 US9833452B2 (en) 2010-12-06 2016-07-11 Compounds
US15/621,400 US10265316B2 (en) 2010-12-06 2017-06-13 Hydantoin derivatives useful as Kv3 inhibitors
IL253104A IL253104A0 (en) 2010-12-06 2017-06-22 Hydantoin derivatives useful as kv3 inhibitors
IL253102A IL253102B (en) 2010-12-06 2017-06-22 Hydantoin derivatives useful as kv3 inhibitors
US15/730,559 US10098881B2 (en) 2010-12-06 2017-10-11 Compounds
US16/125,148 US10555945B2 (en) 2010-12-06 2018-09-07 Compounds
US16/285,996 US20190192516A1 (en) 2010-12-06 2019-02-26 Hydantoin derivatives useful as kv3 inhibitors
US16/725,709 US10835534B2 (en) 2010-12-06 2019-12-23 Compounds
US16/985,160 US11197859B2 (en) 2010-12-06 2020-08-04 Hydantoin derivatives useful as Kv3 inhibitors
US17/030,268 US11541052B2 (en) 2010-12-06 2020-09-23 Compounds
US17/517,620 US11583527B2 (en) 2010-12-06 2021-11-02 Hydantoin derivatives useful as Kv3 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1113757.7A GB201113757D0 (en) 2011-08-10 2011-08-10 Novel compounds

Publications (1)

Publication Number Publication Date
GB201113757D0 true GB201113757D0 (en) 2011-09-21

Family

ID=44735693

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1113757.7A Ceased GB201113757D0 (en) 2010-12-06 2011-08-10 Novel compounds

Country Status (1)

Country Link
GB (1) GB201113757D0 (en)

Similar Documents

Publication Publication Date Title
GB201114103D0 (en) Novel compounds
GB201106799D0 (en) Novel compounds
GB201107325D0 (en) Novel compounds
GB201116641D0 (en) Novel compounds
GB201109763D0 (en) Compounds
GB201106395D0 (en) Compounds
GB201112607D0 (en) Novel compounds
GB201107197D0 (en) Compounds
GB201111704D0 (en) Novel compounds
EP2717694A4 (en) Novel compounds
GB201122113D0 (en) Novel compounds
GB201110938D0 (en) Compounds
GB201105659D0 (en) Compounds
GB201121357D0 (en) Novel compounds
GB201121358D0 (en) Novel compounds
GB201121360D0 (en) Novel compounds
GB201118658D0 (en) Novel compounds
GB201115319D0 (en) Novel compounds
GB201115321D0 (en) Novel compounds
GB201114399D0 (en) Novel compounds
GB201113761D0 (en) Novel compounds
GB201113764D0 (en) Novel compounds
GB201113766D0 (en) Novel compounds
GB201113757D0 (en) Novel compounds
GB201111409D0 (en) Novel compounds

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: AUTIFONY THERAPEUTICS LIMITED

Free format text: FORMER OWNER: GLAXO GROUP LIMITED

AT Applications terminated before publication under section 16(1)